UNI-EN 10:Annual Consolidated Audited Financial report for 2018 of Sopharma Group
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
|
| UNI - EN REPORT No | 10 | / | 2019 | |||||||
| Date of issue: | 2019-04-25 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Annual Consolidated Audited Financial report for 2018 of Sopharma Group | |||||||||||
| Official market - legal basis | |||||||||||
| art. 56. 1. 2 of Act on Public Offering. | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Sopharma Group Financial report according to IFRS as at 31 December 2018 consolidated Sopharma Group Notes to the financial report as at 31 December 2018 consolidated Sopharma Group Management report as at 31 December 2018 consolidated Sopharma Group Financial report according to BFCS standards as at 31 December 2018 consolidated Sopharma Group Declaration as at 31 December 2018 consolidated Sopharma Group Auditor's report as at 31 December 2018 consolidated Sopharma Group Auditor's declaration as at 31 December 2018 consolidated Sopharma Group Corporate governance report as at 31 December 2018 consolidated Sopharma Group Nonfinancial declaration as at 31 December 2018 consolidated Sopharma Group List of insider information as at 31 December 2018 consolidated Sopharma Group Financial report according to IFRS in Excel as at 31 December 2018 consolidated | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| 3JR_Annual_audited_consolidated_FS_2018_EN.rar 3JR_Annual_audited_consolidated_FS_2018_EN.rar | Annual Consolidated Audited Financial report for 2018 of Sopharma Group | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2019-04-25 | Ognian Donev | Executive director | |||
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to 8.3 PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.
